---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-003492"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2026-05-15T22:13:27+00:00"
generated_at: "2026-05-18T10:09:08.718759+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Axe Compute signs $260M contract, Q1 net loss $7.7M, first compute revenue

## Summary
- $260M 36-month take-or-pay contract for 2,304 NVIDIA B300 GPUs; deployment Q3 2026, expected $21M/quarter revenue.
- Q1 2026 net loss $7.7M ($0.36 EPS) on $35K revenue; includes $4.3M non-cash mark-to-market loss on digital assets.
- First compute services revenue recognized; contract liabilities $645K from customer prepayments.
- Appointed Kyle Okamoto President and Jeremy Yaukey-Witter CFO; evaluating sale of Drug Discovery business.
- Liquidity $36.5M: $6.9M cash, $20.2M in ATH digital assets, $9.4M current digital asset receivable.

## SEC filing metadata
- accession: 0001171843-26-003492
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2026-05-15T22:13:27+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184326003492/0001171843-26-003492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184326003492/f8k_051526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-003492
- JSON: https://secwatch.observer/filing/0001171843-26-003492.json
- Plain text: https://secwatch.observer/filing/0001171843-26-003492.txt

## Key facts
- Earnings Releases
  Axe Compute Inc. reported first quarter ended March 31, 2026 results: revenue $35 thousand, net income $7.7 million, EPS $0.36 per share.
  - Period: first quarter ended March 31, 2026
  - Revenue: $35 thousand
  - Net income: $7.7 million
  - EPS: $0.36 per share
  - Result: reported results
  source text: FIRST QUARTER 2026 FINANCIAL HIGHLIGHTS Total Revenue: $35 thousand in Q1 2026, compared to $110 thousand in Q1 2025. The Q1 2026 sales primarily reflects sales from the legacy Drug Discovery Services segment, with $7 thousand contributed by the Compute Services segment reflecting a handful of initial contract deployments that commenced in late March 2026 and will contribute revenue over the respective contract service periods beyond March 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184326003492/0001171843-26-003492-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.